Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

Abstract

DP occurred in the majority of patients with advanced jejunoileal NETs, with median PFS being 36 months. Ki67 was a significant predictor of DP and should be considered in determining appropriate treatments and planning follow-up for these patients.